Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,511 | 1,922 | 98.4% |
| Education | $358.33 | 19 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,623 | 296 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,621 | 160 | $0 (2024) |
| PFIZER INC. | $2,019 | 179 | $0 (2024) |
| ABBVIE INC. | $1,738 | 214 | $0 (2024) |
| Lilly USA, LLC | $1,364 | 94 | $0 (2024) |
| Amgen Inc. | $1,278 | 88 | $0 (2024) |
| Allergan, Inc. | $1,114 | 156 | $0 (2020) |
| Merck Sharp & Dohme LLC | $981.84 | 124 | $0 (2024) |
| Astellas Pharma US Inc | $936.16 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $880.45 | 111 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,846 | 186 | ABBVIE INC. ($477.82) |
| 2023 | $2,730 | 205 | ABBVIE INC. ($415.95) |
| 2022 | $2,598 | 206 | ABBVIE INC. ($395.13) |
| 2021 | $3,047 | 255 | Novo Nordisk Inc ($404.18) |
| 2020 | $2,538 | 208 | AstraZeneca Pharmaceuticals LP ($404.92) |
| 2019 | $2,959 | 283 | Novo Nordisk Inc ($370.54) |
| 2018 | $2,996 | 300 | Novo Nordisk Inc ($487.95) |
| 2017 | $3,156 | 298 | AstraZeneca Pharmaceuticals LP ($467.31) |
All Payment Transactions
1,941 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: PAIN | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: Biological | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: Oncology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Genetic Disease | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 794 | 1,014 | $169,947 | $68,739 |
| 2022 | 13 | 1,092 | 1,254 | $188,600 | $79,278 |
| 2021 | 15 | 1,182 | 1,430 | $196,941 | $84,961 |
| 2020 | 22 | 1,296 | 1,737 | $225,243 | $86,029 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 371 | $85,330 | $28,292 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 247 | $38,285 | $13,926 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $14,994 | $7,952 | 53.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 91 | $8,372 | $6,289 | 75.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $7,322 | $3,022 | 41.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $3,336 | $2,997 | 89.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 93 | $2,325 | $2,254 | 96.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $4,452 | $1,861 | 41.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 30 | $2,910 | $1,013 | 34.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 43 | 43 | $1,806 | $777.87 | 43.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $275.00 | $269.50 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 27 | $540.00 | $85.25 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 337 | $77,510 | $23,782 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 152 | 152 | $36,176 | $19,438 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 240 | $37,200 | $12,561 | 33.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 115 | 119 | $10,948 | $8,003 | 73.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $3,058 | $2,993 | 97.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 117 | 121 | $3,025 | $2,968 | 98.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 118 | 118 | $4,956 | $2,197 | 44.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $4,823 | $1,967 | 40.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 26 | 26 | $1,716 | $1,628 | 94.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $4,494 | $1,498 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 32 | $3,104 | $1,287 | 41.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 34 | $850.00 | $838.75 | 98.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 33 | 37 | $740.00 | $117.50 | 15.9% |
About Dr. Julie Floyd, M.D
Dr. Julie Floyd, M.D is a Family Medicine healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679537070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Floyd, M.D has received a total of $22,869 in payments from pharmaceutical and medical device companies, with $2,846 received in 2024. These payments were reported across 1,941 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($22,511).
As a Medicare-enrolled provider, Floyd has provided services to 4,364 Medicare beneficiaries, totaling 5,435 services with total Medicare billing of $319,007. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fredericksburg, VA
- Active Since 04/13/2006
- Last Updated 08/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679537070
Products in Payments
- FARXIGA (Drug) $1,414
- Ozempic (Drug) $1,075
- VRAYLAR (Drug) $891.37
- UBRELVY (Drug) $774.87
- JARDIANCE (Drug) $739.03
- NURTEC ODT (Drug) $646.18
- JANUVIA (Drug) $551.82
- EVENITY (Biological) $547.26
- PREVNAR - 13 (Biological) $547.14
- Victoza (Drug) $506.21
- EMGALITY (Drug) $504.68
- ELIQUIS (Drug) $486.06
- XARELTO (Drug) $473.47
- BREZTRI (Drug) $455.75
- XIFAXAN (Drug) $441.22
- QULIPTA (Drug) $423.12
- REXULTI (Drug) $375.68
- SOLIQUA 100/33 (Biological) $353.66
- Tresiba (Drug) $317.44
- TRELEGY ELLIPTA (Drug) $315.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fredericksburg
Dr. Dana Brown, M.d, M.D
Family Medicine — Payments: $23,280
Wilson Cook, M.d, M.D
Family Medicine — Payments: $19,339
Rafael Hernandez, M.d, M.D
Family Medicine — Payments: $19,174
Dr. Steven Ma, Md, MD
Family Medicine — Payments: $14,912
Dr. Nelson Henry, M.d, M.D
Family Medicine — Payments: $14,770
Donna Gamache, M.d, M.D
Family Medicine — Payments: $11,509